Literature DB >> 20146552

Practice strategies to improve compliance and patient self-management.

Charles Ruetsch1.   

Abstract

BACKGROUND: Failure in treating opioid dependence is costly to the patient, the employer, managed care organizations, and the overall health care system. Opioid dependent patients tend to be less productive at work and in society and utilize a great many health care resources. Optimizing outcomes is essential.
OBJECTIVE: To introduce the benefit of integrated strategies and patient support in the treatment of opioid dependence.
SUMMARY: Health Analytics is currently studying the benefit of HereToHelp, a behavioral support program in which registered nurses or addiction treatment counselors with specialized training in addiction education provide information and encouragement to patients receiving pharmacologic treatment for opioid dependence. A total of 470 physicians in 41 states have been enlisted to participate in this patient support study. The study hypothesis is that patients who receive behavioral support and encouragement will be more compliant with their opioid replacement therapy, leading to better outcomes. Additional treatment strategies are also being developed to minimize the risk of abuse and diversion. Prodrugs and vaccines are also being investigated.
CONCLUSION: A coordinated team approach is essential in treating pain patients and opioid-dependent patients. Offering behavior modification in addition to pharmacotherapy and utilizing strategies such as prescription monitoring programs, pain contracts, and screening are all vital components necessary for positive outcomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146552     DOI: 10.18553/jmcp.2010.16.s1-b.26

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


  1 in total

1.  Effect of Emotional Intelligence Training on Methadone-Treated Methamphetamine Users in Qazvin, Iran.

Authors:  Seyed Mohsen Zamir; Mahshid Khazaei; Seyed Hossein Ghafeleh-Bashi; Samira Dodangeh
Journal:  Addict Health       Date:  2022-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.